- Home
- MRTN vs GHRS Comparison
MRTN vs GHRS Comparison
Compare MRTN & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRTN | GHRS |
|---|---|---|
| Founded | 1946 | 2018 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 850.3M | 892.0M |
| IPO Year | 1986 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MRTN | GHRS |
|---|---|---|
| Price | $11.78 | $12.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $19.00 | ★ $30.11 |
| AVG Volume (30 Days) | ★ 761.1K | 247.9K |
| Earning Date | 01-26-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $903,976,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.24 | N/A |
| P/E Ratio | $49.75 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.35 | $6.72 |
| 52 Week High | $17.43 | $20.50 |
Technical Indicators
Market Signals| Indicator | MRTN | GHRS |
|---|---|---|
| Relative Strength Index (RSI) | 74.03 | 37.38 |
| Support Level | $11.03 | $13.94 |
| Resistance Level | $11.93 | $15.00 |
| Average True Range (ATR) | 0.30 | 0.86 |
| MACD | 0.16 | -0.23 |
| Stochastic Oscillator | 91.33 | 4.37 |
Price Performance
Historical ComparisonAbout MRTN Marten Transport Ltd.
Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.